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ABSTRACT 
Previous studies with oral bacterial and fungal pathogens have 
demonstrated that histatin 5 is the most potent histatin, a group 
of histidine-rich salivary proteins present in parotid secretions 
with respect to antibacterial and antifungal effects. The present 
study was aimed at investigating the ef feet of human parotid 
salivary histatin? on the viability of the periodontal pathogen 
Porphyromonas gingivalis (P.g.). Experimentally, the viability of 
P.g. was studied after exposure to incremental doses of histatin 5 
at different pH values (pH 5.0, 6.0, 7.0 and 8.0). Histatin 5 from 
human parotid secretion was isolated by Bio-Gel P-2 chromatography 
and reverse-phase high-performance liquid chromatography. The 
purity of histatin 5 was determined by polyacrylamide gel 
electrophoresis and amino acid analysis. 
Following incubation, bacteria were washed by successive 
centrifugation, plated onto enriched Trypticase soy agar, and 
incubated anaerobically at 37 °C. After 48 hr, colony forming units 
were counted. Linear regression analysis was used to evaluate dose-
response. The most perfect fit for a linear regression was found 
for pH 6.0 and 7.0 (p<0.02) with corresponding LD50 values of 0.19 
mM and 0.51 mM, respectively. 
The data indicate that histatin 5 is bactericidal on R..s.. 
gingivalis and this effect is modulated by the pH values of the 
bacterial environment in contact with histatin 5. The relative 
bactericidal potency was higher at pH 5. 0 and decreased as pH 
increased. 
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INTRODUCTION 
Porphyromonas gingivalis is a Gram-negative, strictly 
anaerobic, assacharolytic coccobacillus forming black-pigmented 
colonies on blood agar plates. The role of P. gingivalis in various 
forms of periodontal disease is well established. This suspected 
periodontal pathogen has been shown to produce disease in animal 
models and has been connnonly found in destructive periodontal 
lesions in the various forms of periodontal diseases (Slots and 
Listgarten, 1988). 
Human salivary parotid and submandibular secretions contain a 
group of histidine-rich proteins (Azen 1973; Hay 1975; Baum et al. 
1976; MacKay et al. 1984; and Oppenheim et al. 1986) now known as 
histatins (Oppenheim et al. 1988) . These proteins have several 
significant biological activities, such as being selectively 
adsorbed to hydroxyapatite which may represent a precursor of the 
acquired enamel pellicle (Hay 1975), inhibiting hydroxyapatite 
crystal growth from solutions supersaturated with respect to 
calcium phosphate salts (Oppenheim et al. 1986), and exhibiting 
antifungal and antibacterial activities (MacKay et al. 1984; 
Pollock et al. 1984; Oppenheim et al. 1986, 1988; and Xu et al. 
1991) . 
The isolation and the characterization of the primary · 
structure and the description of the anticandidal effect of human 
parotid salivary histatin 5 was first described by Oppenheim and 
co-workers (1988). Ensuing studies with oral bacterial and fungal 
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pathogens have demonstrated that histatin 5 is the most potent 
histatin with respect to antibacterial and antifungal activity 
(Oppenheim et al. 1988; Xu et al. 1991a and b; Kalpidis et al. 
1992) . 
The present study focuses on the effects of histatin 5 on the 
viability of the periodontal pathogen P. gingivalis. Considering 
the variability of the oral environment, variations in the pH 
conditions were investigated with regard to their effect on the 
bactericidal effects of histatin 5 on P. gingivalis. 
3 
LITERATURE REVIEW 
Saliva 
Saliva is the major constituent to the external environment of 
the oral cavity (Langley 1898). It has the most important influence 
on the aqueous portion of the oral cavity (Mandel 1986; Grahn 
1988) . This aqueous portion is called whole saliva, and is a 
complex mixture consisting of glandular salivary secretions, oral 
bacteria and their metabolic products, crevicular fluid, sloughed 
epithelial cells, and food debris. The term glandular secretions 
describes the secretions of the parotid, sublingual, submandibular, 
and minor salivary glands before these secretions enter into the 
oral cavity. The volume of daily secretion of whole saliva ranges 
from 1 to 1.5 liters. 
Saliva is considered to have two major functions (Mandel 
1987). First, it is involved in initial digestion and lubrication 
of the food for passing through the upper digestive tract. This 
contribution to the digestive process is mainly preparative. Saliva 
also plays a gastronomic role by solubilizing many of the food 
components and acting as a medium for interaction with the 
receptors in the taste buds. Second, it protects both the oral soft 
and hard tissues. This protective function can be attributed to its 
lubrication and demulcent properties, maintenance of mucous 
membrane integrity, soft tissue repair, maintenance of ecological 
balance, debridement/lavage, bacterial aggregation interference, 
demineralization/remineralization of teeth, buffering capacity, 
antibacterial/antifungal/antiviral activities, and maintenance of 
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tooth integrity. Also, an inhibition of HIV virus infectivity has 
been reported (Fultz 1986; Fox et al. 1988,1989). 
Saliva is also considered as an easily accessible biological 
fluid that may be used for diagnostic purposes such as cystic 
fibrosis, hyperaldosteronism, Tay-Sachs disease, and concentration 
of certain hormones and drugs, like a digitalis toxicity indicator 
(Mandel 1986; Grahn and Holm 1987). 
A number of salivary gland disorders result in either 
increased or decreased salivary flow (sialorrhea or xerostomia, 
respectively). Of most concern are the disorders that result in 
reduced salivary flow since they increase the incidence of oral 
disease, specially caries (Mandel 1987). 
Salivary proteins 
Saliva plays an important role in the maintenance of oral 
health by exhibiting a variety of host defense functions. Major 
success in salivary research via biochemical studies of saliva and 
salivary secretions has established that specific salivary proteins 
are responsible for most of these functions. Some of these salivary 
proteins have been isolated and extensively characterized making it 
feasible to explore their structure and functional roles. The major 
macromolecules in saliva are proteins. Approximately forty 
different proteins detected by gel electrophoresis (Steiner and 
Keller 1968; Hay 1983). 
In the last 25 years, considerable progress has been made in 
the isolation, identification and characterization of salivary 
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proteins. Some of the salivary proteins isolated, identified and 
characterized from parotid, submandibular, and sublingual 
secretions include acidic proline-rich proteins (PRPs), statherins, 
cystatins, and histidine-rich proteins or histatins (Oppenheim tl 
.a.L.. 1971; Azen 1973; Baum 1976; Schlesinger and Hay 1977; MacKay 
1984; Isemura et al.1986,1987, Oppenheim et al, 1986,1988, Hay tl 
.a.L.. 1988) . Other salivary proteins include amylase, lysozyme, 
secretory Ig A and lactoferrin. Together these proteins represent 
the major macromolecules present in saliva. 
1. Acidic praline-rich proteins 
Human parotid and submandibular secretions contain high 
concentrations of several closely related proline-rich proteins 
(PRPs) . These PRPs account for approximately 70% of the total 
secreted proteins. These proteins can be further divided into 
acidic, basic, and glycosilated PRPs. 
In 1971, Oppenheim et al, isolated and partially characterized 
a group of acidic PRPs (PRP-1,PRP-2, PRP-3, and PRP-4). All four 
appear to have similar chemical composition. Acidic PRPs are 
characterized by an abundance of proline (22-27%), glycine (20-
22%), and glutamic acid and aspartic acid (26-36%) as determined by 
quantitative amino acid analysis. Additional several minor PRPs 
were isolated by Hay and Oppenheim (1974). The relationship of the 
primary structure of six acidic PRPs has been clarified by Hay 
(1988). This include in addition to PRP-1, PRP-2, PRP-3,and PRP-4, 
the isoelectric focusing variants PIF-s and PIF-f. From their 
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primary structures, it can be seen that PRP-1, PRP-2 and PIF-s are 
each 150 residues each with sequence homology except in residues 4 
and 50. Residue 4 is Asp for PRP-1 and PRP-2 and Asn for PIF-s. At 
position, 50 Asn is present in PRP-1, and Asp is present in PRP-2 
and PIF-s. The smaller PRPs (PRP-3, PRP-4, and PIF-f)contain each 
106 amino acid residues and are functionally related to the major 
PRPs. The primary structure of PRP-3, PRP-4, and PIF-f are 
identical with all 106 residues of PRP-1, PRP-2, and PIF-s, 
respectively. All six acidic PRPs contain phosphoserine residues in 
positions 8 and 22. 
Acidic PRPs are also present in other species. Oppenheim .e..t. 
.aL (1979) isolated a protein from the parotid saliva of Macaca 
fascicularis (MPRP) with a molecular weight of 16,000 which showed 
immunological cross-reactivity with human PRPs. The amino acid 
sequence and composition is very similar to that of the human PRPs. 
Comparing the sequence of MPRP with that of PRP-1 showed that 66 of 
115 amino acid residues of MPRP are identical to those present in 
PRP-1. In contrast to the human PRP-1, MPRP contains 25% (w/w) 
carbohydrates comprising six o-glycosidic oligosaccharides 
(Oppenheim et al. 1982,1985). 
The functional roles of acidic PRPs have been identified by 
several investigators. These PRPs bind to hydroxyapatite (HA) [Hay 
1967, 1973; Bennick et al. 1979], bind to ca 2+ ions Bennick et al. 
1981), and inhibit crystal growth of calc ~Ulll phosphate in 
supersaturated solutions (Grahn and Hay 1976, Hay et al. 1979). 
Acidic PRPs are also found to participate in the f.Qrmation of 
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acquired enamel pellicle which protect teeth from decalcification 
(Armstrong 1971; Kousvelari et al. 1980; Bennick et al. 1983). 
When adsorbed onto hydroxyapatite, the acidic PRPs are capable of 
binding numerous bacteria -such as Actinomyces viscosus-, making 
these proteins selective mediators of oral bacterial adhesion to 
dentition (Gibbons and Hay 1988). 
2. Statherins 
Statherin is a small salivary protein which contains 43 amino 
acid residues. The peptides within the statherin family are 
abundant in tyrosine residues and contain adjacent phosphoserines 
in their primary structures. Until recently, only one statherin 
with 43 residues was isolated. Jensen et al. (1991) characterized 
three other variants of statherine with respect to their sequence. 
All are phosphorylated at Ser residues 2 and 3. 
The family of the statherins exhibit various functions. They 
bind with high selectivity to HA (Hay 1973; Moreno et al. 1978; 
Jensen et al. 1991) . This strong affinity of statherin for HA 
suggests that it is a potential precursor of the acquired enamel 
pellicle. Statherin inhibits crystal growth of calcium, it is the 
only salivary protein that inhibits the spontaneous precipitation 
of calcium phosphate salts from supersaturated saliva (Hay et al. 
1979) . 
In addition to PRPs, statherin also binds to oral bacteria. 
When adsorbed onto HA, statherin also binds to A, viscosus (Gibbons 
and Hay 1988) . It has been observed that statherin possesses 
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receptors for type I fimbriae of A. viscosus This binding also 
requires prior adsorption of statherin onto HA (Gibbons et al. 
1988). Despite functional similarities to PRPs, the amino acid 
sequence of statherin and PRPs demonstrate no genetic relationship 
between these two groups of salivary proteins (Azen et al. 1984, 
1985, 1987; Maeda 1985 a and b; Mamula et al. 1985; Sabatini et al. 
1987) . 
3. Cystatins 
Cystatins are a family of cysteine protease inhibitors present 
in body fluids and tissues. Several related cystatins have been 
isolated from submandibular secretions. These salivary secretions 
are of the type II and their structures include two disulfide 
bonds. The salivary cystatins SA, SA-1 and SA-2 are 121 residues in 
length and exhibit approximately 90% homology with each other 
(Isemura et al. 1987; Al-Hashimi et al. 1988; Lamkin et al. 1991a). 
Several cystatins are phosphorylated and bind to HA. One cystatin, 
named CCPI, binds to HA and its affinity for HA is reduced but not 
eliminated by dephosphorylation. Cystatins also inhibit the growth 
of calcium phosphate crystal salts, although this activity is one 
tenth of that of statherin (Shomers et al. 1982). Lamkin et al. 
(1991) localized the phosphate moieties of cystatin SA-III to one 
residue near the amino-terminal region and three serine residues in 
the carboxy-terminal region. 
Like cystatins found in other body fluids, salivary cystatins 
are capable of inhibiting noncompetitively the action of cysteine-
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proteases. Although the primary structure of the salivary cystatins 
is very similar, cystatins vary in their specificity towards 
protease inhibition (Isemura et al. 1984, 1986, 1987; Al-Hahimi .e..t. 
fil. 1988). Cystatin S inhibits papain and ficin, to a lesser degree 
inhibits bromelin and cathepsin C, and has minimal inhibitory 
activity against cathepsin Band clostripan. It is interesting that 
cystatins not only contain the consensus sequence for the cysteine 
protease inhibitory element (residues 56-67), but also contain two 
consensus sequences for serine protease inhibition (residues 74-84 
and 89-118). The synthetic peptide corresponding to these residues 
possess the characteristic tryptic and chymotryptic inhibitory 
activities. However, native cystatins are not capable of inhibiting 
trypsin and chymotrypsin (Saitoh et al. 1991). 
Several biological roles have been proposed for the cystatin 
family. These roles include antimicrobial (Barret et al. 198_6; 
Korant 1988), antiviral (Korant et al.1985, 1988), reduction of 
inflammatory response (Hibino et al. 1980), hormone-like regulatory 
activity (Grubb and Lofberg 1982), and formation of acquired enamel 
pellicle (Ruan et al, 1986). 
4. Histatins (Histidine-rich proteins) 
Azen (1972) described the genetic polymorphism of a group of 
basic human parotid saliva proteins (PB proteins) using an acid-
urea starch gel system. Similar histidine-rich proteins were also 
described by Balkejian and Longton (1973) and further characterized 
by Hay (1975) and Baum et al, (1976, 1977). The histidine-rich 
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proteins (HRPs) comprise a family of at least seven cationic 
components. Baum et al, (1976 and 1977) described a cationic 
polyacrylamide gel electrophoresis system which made feasible to 
separate the seven early described cationic HRPs from human parotid 
saliva. MacKay et al, (1984) also described a method to isolate 
milligram quantities of HRPs from human parotid saliva. Amino acid 
analysis of such partial purified isolation showed the histidine 
was the most abundant amino acid. 
Parotid and submandibular secretions contain several low 
molecular weight histidine-rich peptides (Oppenheim et al. 1986, 
1988; Troxler et al. 1990). The predominant form of these peptides, 
(Oppenheim et al.1988), are histatin 1, histatin 3, and histatin 5 
consisting of 38, 32, and 24 residues, respectively. The name 
histatin was based on their biochemical nature and biological 
activity. Histatin 1 and 3 are products of two different mRNAs and 
it is presumed that histatin 5 is a proteolytic product of histatin 
3. (Oppenheim et al,1988). Of all histatins, only histatin 1 is 
phosphorylated (Oppenheim et al. 1986, 1988). The primary structure 
and functional characterization of a neutral histatin was reported 
by Oppenheim et al, (1986). This n-histatin contains 38 amino acid 
residues, has a molecular weight of 4929 and the predominant amino 
acids are seven histidine, four arginine, three lysine, three 
aspartic acid, three glutamic acid, and one phosphoserine residues. 
Functional studies indicate that n-histatin is an active inhibitor 
of HA crystal growth from solutions supersaturated with respect to 
calcium phosphate salts. This observation suggests that n-histatin 
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might play a role in the stabilization of the mineral-solute 
interaction in oral fluids similar to PRPs and statherins. N-
histatin was also found to be a potent inhibitor of Candida 
albicans germination (Oppenheim et al, 1986). 
In addition to their affinity to HA and inhibitory activity 
with respect to calcium phosphate precipitation, histatins exhibit 
other activities such as anticandidal activity, candidal binding, 
bacterial binding, antimicrobial activity, and P. gingivalis 
hemagglutination and protease inhibition. Since Pollock et al, 
(1984) reported the fungicidal and fungistatic activity of human 
histatins on C. albicans, more detailed studies have been 
published regarding these activities. Histatin 1, 3, and 5 are 
capable of killing both the yeast and mycelial forms of ~ 
albicans (Xu et al, 1991) . The importance of large numbers of 
histidine residues in histatin 5 was concluded when comparing the 
activity of histidine polymers of varying lengths (Santarpia et al, 
1988). The antifungal activity of synthetic peptides of histatin 5 
was compared with the secondary structure determined by CD 
spectroscopy. It was concluded that the peptide adopts a helical 
conformation in cell membranes (Raj et al. 1990) , the loss of 
viability has been found concomitant with the loss of potassium 
from exposed yeast cells suggesting the possibility that these 
peptides can alter the cell membrane permeability as well as cause 
cell membrane damage (Pollock et al. 1984; Oppenheim et al. 1989). 
Xu et al, (1991) observed that histatin 5 is more effective in 
killing blastospores and germ tubes than histatin 3, which is more 
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effective than histatin 1. The blastopore-killing activity is pH 
dependent for histatin 1 and 3, but not for histatin 5. This 
activity is also reduced at higher ionic strengths and divalent 
cation concentrations. Specifically, histatin 3 is the most 
effective histatin inhibiting the transformation of blastospores to 
germ tubes, followed by histatin 5, then histatin 1. In a 
preliminary report by Xu and Oppenheim (1991) using synthetic 
peptides of histatin 3, the candidacidal and candidastatic 
activities of this histatin were localized to the middle third of 
histatin 3 (residues 12 to 25). 
The bactericidal activity of histatins has also been 
studied,although to a less extent. Reports by MacKay et al. (1984) 
demonstrated that a histatin-enriched fraction was capable of 
killing Streptococcus mutans. Histatins 1, 3, and 5 have varying 
activities with regard to killing different strains of S. mutans. 
The bacteriostatic activities also varied among histatins with 
histatin 5 exhibiting the most potent antimicrobial activity of all 
histatins. In a preliminary report by Kalpidis et al. (1992), 
histatins also exhibited bactericidal and bacteriostatic activities 
against Actinomyces viscosus. A. naeslundii. and A. odontolyticus. 
In addition to their antimicrobial activities, histatins exhibit 
other biological activities against bacteria, specifically g__ 
gingivalis. Nishikata et al. (1991) found that histatin 5 inhibits 
the trypsin-like and clostripan activities isolated from L 
gingivalis but not the activity of trypsin nor chymotrypsin. Also, 
histatin 5 binds to P. gingivalis (Murakami et al. 1990a) and 
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inhibits the hemagglutination induced by this bacteria thereby 
inhibiting its colonization (Murakami et al. 1990b) . Finally, 
Mandel (1987) has suggested that the many histidine residues 
present in histatins may act as a buffering agent against the 
organic acids and decrease in pH as a result of bacterial metabolic 
activity. 
5. Other important proteins in saliva 
Mandel and Ellison (1985) reviewed the biological significance 
of the non-immunoglobulin defense system in saliva. This non-immune 
system was considered to be comprised of lysozyme, lactoferrin and 
lactoperoxidase. These proteins are present in saliva as well as in 
other body fluids. 
Lysozyme is a basic protein with a molecular weight of 14,500 
daltons and has a pI of 11 (Balekjian et al, 1969; Raeste 1972; 
Mandel 1976) . Its classic well known antibacterial activity is 
related to the hydrolysis of the 1-4 linkage between 
N-acetylmuramic acid and N-acetylglucosamine which occurs in the 
mucopeptide cell wall of certain microorganisms. Marquis et al. 
(1982) found that lysozyme was able to agglutinate and kill h 
albicans in non-ionic solutions, and increase the fungicidal 
activity of amphotericin Bin culture media. This investigation 
suggested that the fungicidal activity of lysozyme is related to 
the disruption of cell membranes leading to increase the 
permeability of cell membranes. 
Lactoferrin is an iron binding protein with a molecular weight 
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of 78,000, and binds two iron atoms per molecule. Lactoferrin is 
found in parotid and submandibular secretions (Belekjian et al. 
1969; Mason and Heremans 1971; Rogers 1976). Taback et al. (1978a 
and b) found that the concentration of lactoferrin in saliva 
increases dramatically during inflammation of the oral mucosa and 
parotid gland. 
Another important antimicrobial protein in saliva is 
lactoperoxidase (LPO). LPO has a molecular weight of 77,500 daltons 
and was first isolated from saliva by Mamsson-Rahemtulla et al. 
(1988). Tenuovo et al. (1977, 1981, 1984) studied the antibacterial 
activity of LPO adsorbed by HA suspended in saliva. The adsorbed 
lactoperoxidase significantly inhibited the acid production of 
dental plaque, suggesting an antimicrobial action in situ, Also, 
significant candidacidal activity was observed when c. albicans 
was incubated with a conjugate of LPO, xanthene oxidase, and 
specific antibody against c. albicans (Okuda et al, 1980). 
Tenuovo and co-workers (1986) investigated the maturity of the 
non-immunoglobulin antimicrobial salivary system. They compared 
healthy adults with infants (0.8 to 3.8 years). They observes that 
the non-immune antimicrobial salivary system was at the adult level 
during early childhood, when the protective antibody system was 
still immature. It seems likely that the non-immune system present 
in salivary secretions provides first-line protection against 
pathogenic microorganisms during early stages of human life, when 
the immune system is still immature. 
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Pomhyromonas gingivalis and its relation to Periodontal Diseases 
Periodontal diseases are the result of the interaction of 
bacterial plaque and the host which leads to the destruction of the 
attachment apparatus to the tooth. The majority of the evidence 
that implicates microorganisms as the primary etiologic agents in 
the pathogenesis of periodontal diseases arises from the 
association of microbial plaque to gingivitis and periodontitis, 
and the association of specific bacteria with specific forms of 
periodontal diseases. A significant amount of evidence suggests the 
role of bacteria as the primary etiologic agent of inflammatory 
periodontal diseases (Listgarten 1988). Loe, Theilade and Jensen, 
in 1965, used the experimental gingivitis model in man to 
demonstrate a positive correlation between the amount of microbial 
plaque and the degree of gingival inflammation. They also 
demonstrated the reversibility of the inflammation when plaque was 
removed from teeth. Lindhe, Hamp and Loe (1973 and 1975) also 
demonstrated, in the dog model, the role of microbial plaque in the 
etiology of periodontal diseases. They showed that long-standing 
bacterial deposits result in gingivitis which can develop into 
periodontitis. However, the progression of gingivitis to 
periodontitis in not completely clear (Page 1986). 
Several studies have attempted to established the role of 
specific bacteria in the etiology of periodontal diseases. These 
studies led to developing the specific plaque hypothesis (Loesche 
1976). Since the development of this theory, numerous studies have 
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attempted to characterize the microbiota of the different forms of 
periodontal diseases (Maiden 1990). Socransky and Haffajee (1992) 
defined specific plaque as the presence of suspected pathogens and 
the absence of beneficial species. 
1. Po:r::phyromonas gingivalis 
..... 
P. gingivalis is an intensively studied "probable" periodontal 
pathogen, it is implicated as a major periodontal pathogen in 
periodontal diseases (Slots and Listgarten, 1988). Isolates of this 
species are gram negative, strictly anaerobic, nonmotile, 
asaccharolytic rods that usually exhibit caecal to short rod 
morphologies in solid mediums. P. gingivalis, previously known as 
Bacteroides gingivalis, is a member of the "black-pigmented" 
Bacteroides group. Organisms of this group form brown to black 
colonies on blood agar plates and were initially grouped into a 
single species, Bacteroides melanonigenicus (Shah and Collins, 
1988) . The black-pigmented Bacteroides have a long history of 
association with periodontal diseases. P. gingivalis produces a 
large array of virulence factors. Among this factors are: 
collagenase, trypsin-like activity, fibrinolysin, other proteases, 
phospholipase a phophatases, endotoxin, H2S, NH3, fatty acids, and 
factors which adversely affect polymorphonuclear lymphocytes 
(Socransky and Haffajee 1989). Several studies have produced 
available data that suggests P. gingivalis as a possible etiologic 
agent of destructive periodontal diseases. 
Studies have associated P. gingivalis with periodontal 
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diseases and demonstrated that the species was uncommon and in low 
numbers in health and gingivitis but more frequently detected and 
in elevated numbers in destructive periodontal diseases. The 
species has been shown to be educed and sometimes undetected in 
successfully treated sites but is commonly encountered in recurrent 
disease sites post-therapy (Bragd et al. 1987; Socransky and 
Haffajee 1993). 
Finally, the host response is also an indication of the 
association of P. gingivalis with periodontal diseases. This 
bacteria has been shown to induce elevated systemic and local 
innnune responses in subjects with various forms of periodontal 
diseases. The consensus of the antibody studies is that many 
subjects who has experienced periodontal attachment loss exhibit 
elevated antibody to antigens of P. gingivalis suggesting that this 
species has gained access to the periodontal tissues and may have 
initiated or contributed to the periodontal destruction (Socransky 
and Haffajee 1989, 1993). 
2. Clinically healthy patients 
The microbial composition of a clinically healthy sulci 
consists mainly of facultative anaerobic, gram-positive cocci and 
rods with only a few gram-negative anaerobic organisms (Slots 1977, 
Newman et al. 1978). The ratio of motile to non-motile forms is 
approximately 1 to 40 (Listgarten and Hellden 1978). 
3. Localized juvenile periodontitis 
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In an attempt to understand and explain the unique 
characteristics of juvenile periodontitis (JP), the microbiota 
associated with this disease has been the subject of numerous 
studies. Newman et al. (1976) found a predominant cultivable 
microbiota from the pockets of individuals diagnosed as having 
periodontosis (now known as JP). Although these microbiota were not 
identifiable due to a deficiency in classification schemes at that 
time, the authors came up with five "periodontosis groups." These 
groups were primarily gram negative anaerobic rods from diseased 
sites. Of the five groups, the most common organisms detected were 
from Group II, the Capnocytophaga species, and Group IV which were 
gram negative, saccharolytic Bacteroides-like organisms. Other 
unclassified gram-negative rods and some spirochetes were also 
detected. Even then, the authors concluded that the finding of 
large numbers of specific types of gram-negative anaerobic rods in 
periodontosis lesions suggest the possibility that they may 
contribute to the pathology seen in periodontosis. 
Mouton, in 1981, found that 50% of individuals with 
generalized JP had high levels of immunoglobulin G antibodies to~ 
gingivalis. Capnocytophaga specie was also, along with A.i-
actinomycetemcomitans. a prime suspect in the etiology of JP 
(Newman 1976). On the other hand, Vandesteen (1984), in his study 
of a family with Rapidly progressive periodontitis and JP found the 
pocket flora to be predominantly gram-negative, anaerobic rods with 
a high prevalence of Bacteroides species in the pockets. Wilson et 
al. in 1985 showed similar results with P. gingivalis constituting 
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up to 16% of the cultivable microbiota in the periodontal pocket of 
a JP patient. A. actinomycetemcomitans was recovered in smaller 
numbers. No A, actinomycetemcomitans or antibodies specific to any 
of the serotypes were detected. 
Because of these and other conflicting studies, it may be 
concluded that not all JP patients will predictably present with 
detectable levels of Actinobacillus species in their periodontal 
pockets. These patients may in fact present with a different 
microbiota - the Bacteroides species- and antibodies specific to 
these species in their serum. 
4. Rapidly progressive periodontitis 
Few investigators have reported on the microbial etiology of 
rapidly progressive periodontitis (RPP). It is important to 
remember that the bacterial species associated with RPP are not 
sole etiologic agents for this form of periodontal disease and thus 
should be expected to be found in other forms of periodontal 
disease. 
Rapidly progressive periodontitis was first described by Page 
and coworkers in 1983. One of the features described by these 
investigators was the microbiological composition of a group of 
patients diagnosed with this disease. Serum antibody levels to 
different periodontal pathogens were used to determine the presence 
of these microorganisms. Only six patients were assessed for 
microbiology. P, gingi val is antibodies were elevated in 4 of 6 
patients; Actinobacillus actinomycetemcomitans antibodies were also 
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elevated in 4 of the 6 patients. An interesting finding was that in 
patients with elevated antibody levels to A. actinomycetemcomitans 
the clinical status of the disease was active to highly active. 
Page et al. (1983) also reported that in 22 other RPP patients, all 
except two have had significant titters against antigenic 
determinants of P. gingi val is. A. actinomycetemcomitans, or to 
both. 
Tanner et al. in 1984 cultured patients with rapidly 
progressive lesione which were determined radiographically. They 
cultured active and inactive lesions. The active lesions harbored 
high proportions of P. gingivalis and spirochetes when compared to 
inactive lesions. 
Already establishing the presence of P. gingi val is in RPP 
patients, Martin et al. (1986) found immunoglobulin reactivity to 
this microorganism in these patients. However, not to the same 
extent of adult periodontitis patients suggesting a host/systemic 
influence in RPP. 
van Winkelhoff et al. ( 1989) sampled 11 RPP patients. All 
patients were subgingivally infected with A. actinomycetemcomitans, 
3/11 were infected with P. gingivalis, and 5/11 were infected with 
Prevotella intermedia. The difference between active and inactive 
sites was not established when samples were taken. They concluded 
that the presence of these pathogens is a common finding when 
sampling RPP patients. 
A significant increase in the proportions of Bacteroides 
species, P, gingi val is and P, intermedia, in lesions of RPP 
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patients was reported by Masunaga and coworkers (1990) . After 
therapy, the levels of these pathogens decreased suggesting their 
etiologic role in RPP. In addition, the work of Cao (1991), using 
antibody levels in RPP patients, revealed a 100% positive antibody 
titer to P. gingivalis, whereas the control group only had a 30% 
positive response to the antibody titer of P. gingivalis. 
5. Adult periodontitis 
Adult periodontitis is the most common form of destructive 
periodontal disease. The microbial etiology of chronic adult 
periodontitis is not well understood. A review of the literature 
shows the association of several bacterial species with periodontal 
breakdown; however, not as reliable and specific as the pathogens 
associated to juvenile periodontitis. 
In general, the healthy periodontium is predominated by 
nonmotile rods and cocci (Listgarten and Hellden 1978). In chronic 
adult periodontitis, motile rods and spirochetes increase in 
number. 
Listgarten and Levin (1981) studied chronic adult 
periodontitis patients on maintenance therapy and found an increase 
of attachment loss in patients who had high levels of spirochetes 
and rods. Their results are bolstered by the fact that their study 
was prospective in nature - their microbial measurements were taken 
prior to clinically detectable signs. This illustrates the 
possible usefulness of microbial testing in refractory cases of 
periodontitis. Slots (1979) showed that the flora reverts back to 
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gram positive facultative organisms after the disease has been 
successfully treated. 
In general, it is the anaerobic segment of the microbial 
population that is responsible for periodontal disease. Lindhe et 
al. {1983) tested this hypothesis with the use of a metronidazole 
probe. Anaerobic bacteria are much more sensitive to the 
bactericidal effects of metronidazole than aerobic or facultative 
bacteria. Lindhe found that the administration of metronidazole 
eliminated the clinical {plaque, gingivitis, increase in probing 
depth, loss of attachment level) and histological signs of 
inflammatory periodontal disease. This confirms the role of 
anaerobic bacteria in chronic adult periodontitis. 
In order for a specific organism to be considered a 
periodontal pathogen, it must fulfill the following criteria: 
colonization of the periodontal environment, resistance of host 
defense, creation of tissue damage either directly through 
endotoxin, or indirectly through the propagation of a damaging host 
response reaction {Slots and Genco 1984). 
Three of the primary organisms that exhibit these properties 
are A, actinomycetemcomitans. P. gingivalis. and P. intermedia. P. 
gingivalis and P. intermedia inhibit neutrophil chemotaxis and 
aggregation of complement proteins. 
Slots {1986) investigated the relationship of a,_ 
actinomycetemcomitans. P, intermedia and P. gingivalis to chronic 
adult periodontal disease. He assessed the status of periodontal 
activity through probing depth and radiographic crestal alveolar 
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bone height. Slots admits that these methods of assessing disease 
activity are of limited value in the short term, but are reasonably 
good measures when taken over an extended period. The bacteria 
were sampled using an anaerobic technique and identified using 
selective/nonselective media and immunofluorescence. All of the 
aforementioned bacterial species were found more frequently and in 
greater numbers in the progressing lesions than in the 
nonprogressing lesions. 
Socransky (1987) blatantly disagrees with Slots' assessment. 
Socransky demonstrated a poor correlation between microbiological 
and clinical data such as probing and radiographs. Furthermore, 
Socransky and Haffajee point out in their 1992 review article that 
the mere presence of these pathogenic bacteria is not enough to 
initiate periodontal disease activity; a host of other factors are 
necessary. For instance, the host must be susceptible and the 
pathogenic bacteria must be present in large enough numbers. In 
addition, the beneficial species of bacteria must not be present in 
enough numbers to deter the disease process. 
Antibody studies give added weight to the relationship of .E...:.. 
gingivalis to periodontitis. Vincent et al. (1985) showed that the 
serum antibody level to P. gingivalis increases in patients with 
chronic adult periodontal disease. However, his study did not show 
different antibody levels of A, actinomycetemcomitans in healthy 
versus diseased individual, which sheds doubt on his findings. 
Slots and Listgarten examined the relationship of ~ 
actinomycetemcomitans. P, gingivalis and P. intermedia to 
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periodontal disease somewhat more closely in their 1988 review 
article. While they believe that those three are the predominant 
pathogens, they also include other possible pathogens: c, rectus. 
B. forsythus, and E. corrodens. Also included are Fusobacterium 
and Treponema species. The authors explain that ~ 
actinomycetemcomitans. P. gingivalis and P. intermedia must all be 
considered to determine if a site is progressing or not. For 
instance, P. intermedia was found in 38% of nonprogressing sites; 
perhaps, the authors ponder, because of its association with 
gingivitis. This shows very poor specificity, eliminating the 
possibility of using P. intermedia as a sole test for chronic adult 
periodontal disease activity. 
In 1991, Haffajee et al. gave an updated list of suspected 
periodontal pathogens: A. actinomycetemcomitans serotypes a and b, 
B. forsythus. F. nucleatum. P. micros. P. gingivalis. P. intermedia 
homology groups I and II, and C. rectus. These were derived from 
longitudinal studies using clinical measurements, microbiology, and 
immunology to measure disease activity. They were also able 
identify several "beneficial" species, species who presence 
predisposes a particular site to a state of health. These species 
include c. ochracea. s, sanguis, and v. p.aryula. 
Slots et al. (1985) performed a study utilizing split mouth 
design: one side of the mouth had subgingival scaling and the other 
did not. Probing depth and probing attachment level were monitored 
over twelve months. Paper point sampling was used to detect L 
gingivalis and P. intermediaf spirochetes and motile rods. Results 
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showed an increase in the numbers of study organisms in regions 
with deeper residual pocket depths. 73% of the sites with a 2mm or 
more increase in probing depth had P. gingivalis present. ~ 
gingivalis was not found in 27% of the active lesions. The authors 
attempt to justify this discrepancy by pointing out that ~ 
actinomycetemcomitans, another potential pathogen, was not tested 
for in this study. Therefore, any clinical microbial testing 
device using P. gingivalis as an indicator might misdiagnose active 
disease 27% of the time, making this diagnostic tool grossly 
inaccurate. 
Moore et al. (1991) also made an attempt to differentiate 
between the flora associated with actively progressing sites of 
periodontal disease and those sites that were not actively 
progressing. He samples 20 adult periodontitis patients every 2 to 
4 months for 2 years. Non-progressing sites in the same subjects 
served as controls. The results showed that there was no 
statistical difference in the amounts or types of bacterial species 
between active and inactive sites. This study sheds doubt on any 
attempt to use bacterial testing as a predictor of disease 
activity. 
6. Refractory periodontitis 
Refractory periodontitis is a disease classification used to 
define sites in patients who continue to be infected with certain 
periodontal pathogens, and who experience a high rate of attachment 
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and tooth loss despite intensive and apparently appropriate 
treatment (Haffajee et al. 1988). It is logical to question what is 
different in patients who respond well to therapy and "refractory" 
patients. The answer to this might be related to the type of 
persistent bacteria in these non-respondent sites. 
Haffajee and coworkers (1988) reported the microbiological 
features of patients with refractory periodontal disease. 
Refractory sites exhibited elevated levels of B, forsythus. F. 
nucleatum. s. intermedius. E. corrodens, and P. gingivalis. 
However, subjects differed in the combinations of predominant 
species. Refractory subjects did not constitute a homogenous group. 
Three major microbial complexes were observed in this study: 1) IL.. 
f orsythus. F. nucleatum, and w. rec ta; 2) s. intermedius. P, 
gingivalis, and P. micros; and 3) s. intermedius. F. nucleatum with 
or without P. gingivalis. 
Walker and Gordon (1990) studied the effect of clindamycin on 
the microbiota of refractory patients. The results of the 
microbiological analysis of active sites were: 30% spirochetes, 22% 
motile rods, 10% coccoid forms, and 38% non-motile rods. Non-active 
sites contained 35% spirochetes, 20% motile rods, 13% coccoid 
forms, and 33% non-motile rods. No significant differences were 
detected between active and non-active sites based on dark-field 
microscopic examination. The cultivated and identified microbiota 
recovered from active sites consisted predominantly of L 
intermedia and P. gingivalis. P. intermedia was considerably higher 
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in active sites when compared to controls. The authors concluded 
that the elevated mean percentages of P. intermedia and R._._ 
gingivalis were associated with sites losing attachment, the lower 
percentages present in quiescent sites, and their near absence 
after successful therapy suggest that these microorganisms are 
involved in the destructive process associated with refractory 
periodontitis. 
The presence of P. gingivalis. P. intermedia, and ~ 
actinomycetemcomitans in refractory patients was examined by 
Rodenburg et al. in 1990. A total of 104 patents were sampled. The 
authors reported A. actinomycetemcomitans on 55% of patients, g__,_ 
gingivalis in 27% of patients, and P. intermedia in 59% of 
patients. These results suggests a higher incidence of 
A.actinomycetemcomitans and P. intermedia than P. gingivalis in 
refractory periodontitis. 
A study by van Winkelhoff and coworkers (1992) reported the 
microbiological results of antibiotic therapy on ~ 
actinomycetemcomitans-associated periodontitis. 40 refractory 
periodontitis patients were sampled in this study. This group of 
researchers reported A. actinomycetemcomitans in 100% of the 
patients sampled, P. gingivalis in 23% of patients, and R....,_ 
intermedia in 48% of patients. A correlation between age and the 
presence of the pathogens was established. The mean age of patients 
with~- was lower than the means of patients with P. gingivalis 
and/or P. intermedia. 
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7. "Active" periodontal disease 
Longitudinal studies of the progression of untreated 
periodontal disease have suggested that destructive lesions may 
progress with periods of exarcebation and remission (Goodson et al. 
1983, Haffajee et al. 1983). A few studies have attempted to relate 
periodontal pathogens to periods of active destructive disease. 
Savitt and Socransky (1984) did not found correlation between 
the subgingival microbiota and disease activity. They concluded 
that disease activity is not to be diagnosed on basis of the 
proportion of motile bacteria in the subgingival microbiota. 
The predominant cultivable microbiota of active lesions of 
periodontal disease was monitored by Dzink et al. (1985) in 14 
patients. They found that levels of c, rectus. B. forsythus, and L 
intermedia were elevated in active lesions when compared to 
inactive lesions. The presence of C. rectus in active sites was 
also reported by Tanner et al. (1984) and Moore et al. (1985). In 
1988, Dzink and coworkers sampled 33 subjects with active disease 
determined by the "tolerance" method of analysis (Haffajee et al. 
1983, Dzink et al. 1985). The levels of c, rectus. P. intermedia. 
F. nucleatum. P, gingivalis, and B. fosythus were elevated more 
often in active sites. They concluded that the presence of these 
p~thogens might be used as an indicator of active disease. 
In a retrospective study by Bragd et al. (1987), the 
capability of A. actinomycetemcomitans. P. gingivalis, and .E...... 
intermedia to indicate periodontal disease activity was evaluated. 
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105 nonprogressing sites and 130 progressing sites, detected by 
radiographic bone loss, were sampled. The nonprogresing sites 
revealed a 87% sensitivity and a 84% specificity. The authors 
suggested that the presence of bacteria in samples of progressing 
and nonprogressing sites may be the result and not the cause of the 
disease. Wennstrom et al. (1987) suggested that the diagnostic 
value of a positive test for A, actinomycetemcomitans. P. 
gingivalis, and P, intermedia in detecting future disease activity 
may not be as useful as the negative value of a test to predict 
absence of future disease activity. This is also mentioned by 
Socransky et al. ( 1991) ; they state that the total count of 
microorganisms increase in number with increased pocket depth, 
attachment level, redness, and bleeding on probing. Later, 
Socransky and Haffajee (1992) stated that it is possible to 
demonstrate a positive correlation between the presence of 
suspected pathogens and signs of disease. Such positive 
correlations, however, do not differentiate between organisms that 
are primary pathogens, and opportunistic bacteria that have 
proliferated because of diseased-induced anatomic alterations such 
as deepened pocket depth and shift that have promoted their growth. 
A lack of reliability in predicting future episodes of disease 
activity when A. actinomycetemcomitans. P. gingivalis, and~ 
intermedia were used as indicators was also observed by Listgaten 
et al. in 1991. In their 3 year prospective study of patients on 
maintenance previously treated for periodontal disease, 
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sensitivity, specificity, and predictive values were too low to be 
of any diagnostic value regardless of the diagnostic potential 
demonstrated in previous studies. According to Machtei et al. 
(1993), periodontopathogenic bacteria demonstrate high specificity 
and negative predictive value. However, a low sensitivity and 
positive predictive value may account for the low 
correlation of these microorganisms with active periodontitis. 
However, increased levels of P. gingivalis should be considered as 
risk factors for future periodontal disease. 
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MATERIALS AND METHODS 
1. Biochemical and Microbiological Materials 
Saliva collection 
Human parotid saliva was collected from healthy adult donors 
at Boston University School of Graduate Dentistry. Secretion was 
stimulated using sour lemon flavored candies, and collected in an 
ice-chilled container with the aid of a Carlson-Crittenden device 
as previously described by Curby (1953) . The collected parotid 
saliva was desalted by dialysis against deionized water at 4°C. The 
deionized water was changed every two hours during day time and one 
over night change over a 36 hour period. After dialysis, the saliva 
was lyophilized to dryness and subsequently stored at -20 degrees 
celsius until used. 
Bio-Gel P-2 and electrophoresis reagents were obtained from 
Bio-Rad Laboratories (Richmond, CA). L-1-tosay-amido-phenylehtyl 
chloromethylketone-trypsin (TPCK-trypsin) was obtained from Cooper 
Biomedical (Malvern, PA) ands. aureus vs protease was purchased 
from Miles Laboratories (Naperville, IL) . A TSK-ODS (120T) C18 column 
(5 um) was purchased from LKB (Bromma, Sweeden). Acetonitrile was 
purchased from Baker Chemical Co. (Phillipsburg,NJ). 
Trifluoroacetic acid was purchased from PIERCE (Rockford, IL) . 
Sequencer chemicals were from Applied Biosystems, Inc. (Foster 
City, CA). Polystyrene 96-well microtiter plates were purchased 
from COSTAR (Cambridge, MA). Trypticase soy agar medium,trypticase 
soy broth, yeast extract, dextrose, hemin, cysteine and vitamin K 
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were obtained from Difeo (Detroit, MI). All plates, microvials, 
centrifuge tubes,blood agar plates, and chemicals were from Fisher 
Scientific (Pittsburgh, PA) unless otherwise specified. 
Bacterial strain. P. gingivalis strain ATCC 44830 was 
purchased from American Type Culture Collection (Baltimore,MD). The 
strain was stored in blood agar plates and enriched trypticase soy 
agar (ETSA) plates at 4° C. Enriched trypticase soy agar was 
prepared containing: 
trypticase soy agar ............... . .... 20 gm 
yeast extract ........................... 1 gm 
anhydrous sodium carbonate ........... 0.04 gm 
dextrose ................................ 1 gm 
cysteine ............................. 0. 08 gm 
heroin .................................. 20 mg 
vitamin K .............................. 50 ug 
deionized water ....................... 500 ml 
The culture medium consisted of enriched trypticase soy broth 
(ETSB) containing: 
trypticase soy broth ................... 20 gm 
yeast extract ........................... 1 gm 
anhydrous sodium carbonate ............ 0.4 gm 
dextrose ................................ 1 gm 
cysteine .............................. 0 . 4 gm 
heroin .................................. 10 mg 
vitamin K .............................. 50 ug 
deionized water .......................... 1 1 
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at final pH of 7.0-7.3. The strain was cultured under the strict 
anaerobic conditions N2-co2-H2 (85-10-5) at 37 ° C in an anaerobic 
chamber. Cultures were maintained by weekly transfer on enriched 
trypticase soy agar ·and blood agar plates. Cultures were stored at 
4°C on blood agar plates and on enriched trypticase soy agar plates 
until used. 
Suspension buffers. The standard suspension buffer utilized in 
the bactericidal assay was 10 mM phosphate buffered saline (PBS), 
pH 7. O. To evaluate the effectiveness of histatin 5 over the 
possible pH range occurring in the oral cavity, 10 mM PBS was 
prepared at pH 5.0, 6.0, 7.0, and 8.0. 
2. Biochemical Experimental Procedures 
Isolation of histatins 
Isolation of histatin 5 was done following the procedure 
described by Oppenheim et al. (1988) . One gram of dialyzed and 
lyophilized human parotid saliva was dissolved in 50 ml of 0.05 M 
ammonium formate, pH 4.0. The solution was stirred for 30 minutes 
and centrifugated at 13, 000 rpm for 15 minutes at 10 degrees 
celsius. The supernatant was then chromatographed on a Bio-Gel P-2 
column (polyacrylamide resin) 100-200 mesh equilibrated in the same 
buffer. The chromatography column had 2.6 cm in diameter, 89 cm of 
length, and a 34 ml/hr flow rate. Fractions were continuously 
monitored at 230 nm with Uvicord S (Pharmacia-LKB) and collected at 
30 minute intervals. Fractions containing histatins were pooled, 
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lyophilized, dissolved in 2% acetic acid and subjected to reverse 
phase chromatography (RP-HPLC)on a TSK-ODS (120T) c18 column using 
a LKB high performance liquid chromatography system. Fractions 
containing histatins were collected employing the peak detector 
module of the LKB super rac fraction collector. Solvent A was 0.1% 
trifluoroacetic acid (TFA) in water and solvent B was 0.1 
trifluoroacetic acid, 80% acetonitrile, and 19.9% water. The 80 
minute gradient was run as follows with respect to solvent B; 0-4 
min, 0%; 4-14 min, 10%; 14-64 min, 14-40%; 64-70 min, 40-100%. As 
a general protocol, isolated histatins were evaporated to dryness 
in vacuo, redissolved in 2% acetic acid, and rechromatographed 
isocratically at 15 fractions (lml/min) less solvent B than that 
which released the protein from the column initially. Purified 
histatins were evaporated to dryness, redissolved in distilled 
water, lyophilized, and stored at 20° C until used. 
Amino acid analysis 
Histatin samples were hydrolyzed under 6 N HCl and 1% phenol 
vapor in a Waters PicoTag Station (Milford, MA) at 108°C for 24 
hours. Amino acid analysis were performed on a Beckman System amino 
acid analyzer Sterling, VI). 
Cationic gel electrophoresis 
Samples were subjected to electrophoresis in 15% 
polyacrylamide 1. 5 mm slab gels following essentially the procedure 
of Baum et al. (1976), MacKay (1984), and Oppenheim et al. (1988). 
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The 16 x 20 mm slab gels were fixed in 20% trichloroacetic acid in 
water for 30 minutes at room temperature and stained in 0 .1% 
coomasie brilliant blue R-250 in 7% acetic acid, 8% methanol and 
85% water (v/v) overnight at room temperature. Destaining was 
performed in 7.5% acetic acid, 10% methanol and 82.5% water (v/v) 
for 36 to 48 hours at room temperature. 
Automated Edman degradation 
Histatins and derived peptides were subjected to automated 
Edman degradation using an Applied biosystems,Inc, 470A gas-phase 
sequencer equipped with a model 120 PTH analyzer. 
3. Microbiological Experimental Procedures 
Growth of Microorganisms 
P.gingivalis was grown overnight on enriched trypticase soy 
agar plates at 37 ° C under anaerobic conditions previously 
described. Stationary phase growth bacteria (one loop) were 
transferred from the agar plate to five ml of enriched trypticase 
soy broth and grown overnight under previously described 
conditions. 
To initiate logarithmic phase growth, an aliquot of 0.2 ml of 
grown bacteria were transferred to 4.8 ml of enriched trypticase 
soy broth making sure that the inoculated broth optical density at 
560 nm did not exceed 0.1. P. gingivalis was grown under anaerobic 
conditions previously described until the logarithmic phase of 
growth was achieved, indicated by an optical density of 0.2. Four 
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ml of broth containing P. gingivalis in logarithmic phase of growth 
were transferred into a fifteen ml centrifuge tube. Ten millimolar 
(mM) phosphate buffered saline (PBS) was added to complete a final 
volume of ten ml. Cells were washed three times with phosphate 
buffered saline in centrifuge at 1,500 rpm for five minutes at 4° 
C. Nine ml of supernatant in the centrifuge tube were removed. 
Bacterial cells were resuspended in PBS at a concentration of 1.6 
to 3.8 x 107 cells per ml. 
Bioassay 
Bactericidal assay. Ten ul of cell suspension were added to 
ten ul of protein solution (experimental sample) or buffer solution 
containing no histatin 5 (control sample) in a microtriter plate. 
The experimental concentrations of histatin 5 were 0.1, 0.2, 0.4, 
0.8, 1.6 and 3.3 mM. Experimental and control samples were 
incubated for one hour at 37°c under previously described anaerobic 
conditions. After incubation, aliquots of each experimental and 
control samples were sequentially diluted until a 1x10- 6 dilution 
was achieved. One hundred ul aliquots of each bacterial dilution 
were spread into enriched trypticase soy agar and blood agar plates 
in triplicates and incubated for 48 hours under previously 
described anaerobic conditions. After incubation, the total number 
of colonies on each plate was counted. The bactericidal effect of 
histatin 5 on P. gingi val is was calculated accordingly to the 
mathematical formula: 
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colonies in sample with protein 
killing%= [1- -------------------------------] x 100% 
colonies in control sample 
The bactericidal effect of histatin 5 was evaluated at pH 5.0, 6.0, 
7. 0, and 8. 0. All samples were tested in triplicates for each 
experiment and all bactericidal assays were repeated at least three 
times. 
statistical analysis 
Data were statistically analyzed. The mean and standard 
deviation from triplicate assays were obtained. Linear regression 
analysis was used to evaluate dose-response effect of histatin 5 on 
P. gingivalis at pH 5.0, 6.0, 7.0,and 8.0. From the dose-response 
relationship, doses effecting a 50% killing (LD50) at the different 
pH ranges were determined by probit transformation (Govindarajulu, 
1988) . 
Biochemical procedures 
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RESULTS 
Isolation of histatin 5. One gram of dialyzed and lyophilized 
human parotid saliva was dissolved into 0.05M ammonium formate, pH 
4.0 and loaded into a Bio-gel P-2 column equilibrated in the same 
buffer. The material absorbing at 230 nm was detected in a broad 
tailing zone (Figure 1). Electrophoretic analysis in the 
polyacrylamide gel electrophoresis (PAGE) showed that the material 
corresponding to the broad tailing zone contained a mixture of 
histatins free of other salivary proteins. Three double bands of 
histatins were separated by the cationic PAGE electrophoresis 
system: histatins 1 and 2, 3 and 4, and 5 and 6. The major 
histatins 1, 3 and 5 were well separated by reverse phase high 
pressure liquid chromatography (RP-HPLC) on a C18 column developed 
with an acetonitrile gradient (Figure 2) . His ta tins used for 
structural, functional and biologic studies were resubjected to 
chromatography on the same C18 column under the isocratic conditions 
described in the experimental procedures. After the second RP-HPLC, 
cationic PAGE electrophoresis showed that the major histatins 1, 3, 
and 5 migrated without trace of their closely associated minor 
histatins 2, 4, and 6. The purity of the histatin 5 used for this 
project was also monitored by PAGE electrophoresis. 
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Amino acid analysis. The amino acid composition of histatin 5 is 
shown in Table I. Calculation of the minimum of the minimum 
molecular weight (based on seven histidine residues) indicated that 
histatin 5 contained 28.0 amino acid residues. 
TABLE I. Amino acid composition of histatin s* 
Amino acid Histatin 5 
Asx 1.1 (1) 
Ser 1. 6 (2) 
Glu 1.2 ( 1) 
Gly 2.2 ( 2) 
Ala 1.2 (1) 
Tyr 2.9 (3) 
Phe 1.4 (1) 
Lys 4.2 (4) 
His 7.0 (7) 
Arg 3.2 ( 3) 
*values in parenthesis are residues identified by automated 
Edman degradation. Data from Oppenheim et al. (1988). 
41 
Amino acid sequence. The complete amino acid sequence histatin 
5 was obtained by automated Edman degradation which showed that 
this histatin contains 24 amino acid residues (Figure 3). 
Calculation of the molecular weight of histatin 5 from amino acid 
analysis was 3,037 (Figure 3). 
FIGURE 3. Amino Acid Sequence of Human Histatin 5* 
Histatin 5: 
1 15 
Asp-Ser-His-Ala-Lys-Arg-His-His-Gly-Tyr-Lys-Arg-Lys-Phe-His-
16 24 
Glu-Lys-His-His-Ser-His-Arg-Gly-Tyr 
* Adapted from Oppenheim et al. (1988). 
The above data were previously done and reported by Oppenheim 
and coworkers (1986 and 1988). With the exception of amino acid 
sequence analysis, in the current experiment, all the other 
biochemical procedures were routinely done and used in this 
experiment. 
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BIOLOGICAL ACTIVITIES 
Growth of P . gingi val is . P. gingivalis was grown to the 
logarithmic phase of growth and then was harvested for use in the 
bactericidal assay. This phase of growth corresponded to an 
absorbance of 0.2 at O.D. of 560 nm as calculated in the growth 
curve of P. gingivalis (Figure 4). 
P. gingivalis growth curve 
0 0.8 ······ ..... . ......... ···············•···· .............. •·· ............................................................................ I 
D 
a 0.6 
t 
5 
6 0.4 
0 
n 
m 
0.2 
4 6 
Hours 
8 10 
FIGURE 4. Growth curve for P. gingivalis. Bacterial cells were 
grown in enriched trypticase soy broth. The growth curve was 
plotted as time vs. the optical density of cells in grown media. A 
0.2 absorbance at O.D. 560 nm corresponded to the start of the 
logarithmic growth phase. 
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Bactericidal assay. The ability of histatin 5 to kill .E..:.. 
gingivalis at the different pH conditions of 5.0, 6.0, 7.0, and 8.0 
was investigated (Table II). Histatin 5 killed P. gingivalis 44830 
under physiologic conditions (Figure 5). 
At pH 5.0, histatin 5 had the most potent bactericidal effect 
on P. gingivalis. Regression analysis showed a line of best fit 
with R= 0. 64. An LD50 could not be calculated since the lowest 
concentration tested ( 0. lmM) resulted in a 59% killing of the 
bacteria (Figure 6). 
At pH 6.0, histatin 5 also killed P. gingivalis. Regression 
analysis showed a line of best fit (R= 0.88). Calculations using 
probit transformation estimated a LD50 of 0.19 mM (Figure 7). 
At pH 7.0 (physiologic pH), histatin 5 also had bactericidal 
effect on P. gingivalis. Probit transformation estimated a LD50 of 
0.51 mM and regression analysis showed a line of best fit with 
R=0.89 (Figures 5 and 8). 
At pH 8. 0, the effect of histatin 5 was not significant. 
Histatin 5 had no bactericidal effect on P. gingivalis except at a 
3.3 mM concentration were the killing was 20% (Figure 9). 
The bactericidal potency of histatin 5 on P. gingi val is 
increased as the pH was decreased (Table II). The relative potency 
of overall mean killing percentage at each pH was 91% at pH 5.0, 
78% at pH 6.0, 57% at pH 7.0, and 3% at pH 8.0. A comparison of LD50 
values of histatin 5 on P. gingivalis and other oral pathogens is 
shown in Figure 10. 
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TABLE II. Comparison of bactericidal effects of human salivary 
histatin 5 at different pH conditions.* 
Histatin 5 pH 5.0 pH 6.0 pH 7.0 pH 8.0 
(mM) 
0.1 59 (±15) 34(±12.8) 29 (±6. 9) 0 (±0) 
0.2 92 (±8) 65 (±9) 49 (±5.4) 0 (±0) 
0.4 100 (±0) 69 (±10) 62 (±5.2) 0 (±0) 
0.8 94 (±6) 98 (±1. 56) 64 (±2. 8) 0 (±0) 
1.6 100 (±0) 100 (±0) 68 (±2. 3) 0 (±0) 
3.3 100 (±0) 100 (±0) 82 (±4. 5) 20(±19.5) 
*. Values are given in percentage. Values in parenthesis represent 
standard error. 
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Killing of Porphyromonas gingivalis 
by Histatin 5 at pH 7.0 
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FIGURE 5: Bactericidal ef feet of hi stat in 5 on Porphyromonas 
gingivglis under physiologic conditions. The bar represents the 
mean killing% with the standard error for each concentration. 
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Killing of Porphyromonas gingivalis 
by Histatin 5 at pH 5.0 
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FIGURE 6: Linear regression analysis of killing of ~ and 
histatin 5 concentration at pH 5. 0. The X represents the mean 
killing % and the bar represents the standard error for each 
concentration. A 100 % killing of P.g. was achieved with 0.4 mMol 
histatin 5. Regression analysis showed R=0.64. 
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Killing of Porphyromonas gingivalis 
by Histatin 5 at pH 6.0 
0.2 0.4 0.8 1.6 
Histatin 5 Concentration (mMol) 
3.3 
FIGURE 7: Linear regression analysis of killing of ~ and 
histatin 5 concentration at . pH 6 . 0. The X represents the mean 
killing % and the bar represents the standard error for each 
concentration. A 100 % killing of~ was achieved with 1.6 mMol 
histatin 5. A LD50 of 0 . 19 mMol was calculated by probit 
transformation, regression analysis showed R=0.88 (p< 0.02). 
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Killing of Porphyromonas gingiva/is 
by Histatin 5 at pH 7.0 
100 r-------------------------, 
80 ······················· ··············•······················· 
2or --------------------- ---1 
0.1 0.2 0.4 0.8 
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1.6 
(mMol) 
3.3 
FIGURE 8: Linear regression analysis of killing of P. g. and 
histatin 5 concentration at pH 7. 0. The x represents the mean 
killing % and the bar represents the standard error for each 
concentration. A LD50 of O. 51 mMol was calculated by probit 
transformation, regression analysis showed R=0.89 (p<0.0008). 
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Killing of Porphyromonas gingivalis 
by Histatin 5 at pH 8.0 
so,--------------'---------
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FIGURE 9: Linear regression analysis of killing of ~ and 
histatin 5 concentration at pH 8. O. The X represents the mean 
killing % and the bar represents the standard error for each 
concentration. Only 20 % killing was achieved at highest 
experimental concentration. 
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Microorganism Histatin 5, LD 50 
Mutans of Streptococci 
S. cricetus (AHT) 
S. ratus (BHT) 
S. mutans (JBP) 
S. sobrinus (MB2R) 
S. mutans (LM7) 
S. mutans (OMZ175) 
S. sobrinus (6715) 
Candida albicans 
yeast form 
ATCC32354 (8311) 
ATCC44505 
mycelial form 
ATCC32354 (8311) 
ATCC44505 
P. gingivalis 44830 
21.4 umol 
9.3 umol 
8.9 umol 
15.7 umol 
7.9 umol 
5.3 umol 
16.3 umol 
2.2 umol 
2.0 umol 
8.5 umol 
9.7 umol 
510 umol 
FIGURE 10: Comparison of LD50 values of his ta tin 5 for Porphyromonas 
gingivalis and other oral pathogens. 
* Data from Xu and Oppenheim (1990). 
** Data from Xu et al. (1991) . 
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DISCUSSION 
Periodontal disease is one of the most prevalent diseases 
affecting the oral cavity. A specific bacterial plaque has been 
identified as the probable etiology of the different forms of 
destructive periodontal diseases (Loesche 1976). One of the most 
intensively studied suspected periodontal pathogens is L 
gingivalis. The elimination of this organism from diseased sites is 
compatible with a successful therapy and recurrent lesions harbor 
high levels of this species. Also, elevated levels of this pathogen 
indicate a high risk of disease progression (Socransky and Haffajee 
1992) . 
The non-immune host defense system present in the oral cavity 
is considered to be very important in maintaining oral health. This 
system is comprised of specific salivary proteins which exhibit 
anti microbial activities. An early study by Pollock and coworkers 
(1984) reported the fungistatic and fungicidal activity of a 
mixture of human parotid histidine-rich protein, now known as 
histatins (Oppenheim et al. 1988), on c, albicans. Oppenheim et al. 
(1988) was the first to report the primary structure of histatins 
1, 3 and 5. These proteins are capable of killing C. albicans 
blastospores in a dose-dependent manner. While all three major 
human histatins demonstrated candidacidal activities, they differed 
in their ability to kill both blastoconidia and germinated cells, 
with histatin 5 being the most active (Xu et al. 1991). Xu and 
Oppenheim (1992) reported the possible candidacidal mechanism of 
human parotid histatin 5. Both viability and binding data suggests 
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that the killing mechanism of histatin 5 involves the cell wall to 
a major degree . 
Pollock et al . 
This is in agreement with previous reports by 
(1984) and Oppenheim (1989), where histatin 5 
possibly alters membrane permeability. 
The bactericidal activity of histatins was first reported by 
MacKay et al. (1984). Partially purified mixtures of histatins were 
shown to inhibit the growth of several strains of the mutans 
Streptococci. The bactericidal effect of pure isolates of histatin 
5 on several Streptococci strains were reported by Xu and Oppenheim 
(1990). The bactericidal effect of histatin 5 was calculated and 
LD50 values were determined for each strains. The effect of human 
salivary histatin 5 on several Actinomyces species has been 
determined. The results of this study showed that histatin 5 
exhibits bactericidal activity against Actinomyces viscosus. A. 
naeslundii and A. odontolyticus with complete loss of viability at 
concentrations higher that 40 ug/ml (Kalpidis et al. 1992). 
The present investigation describes the bactericidal effects 
of human parotid salivary histatin 5 on the suspected periodontal 
pathogen P. gingivalis. This study also explored the effect on the 
bactericidal activity of histatin 5 under a variety of pH 
conditions known to occur in the oral cavity, which are dictated by 
that of saliva, ranging between pH 5.0 and pH 8.0. The data of this 
investigation showed the ability of histatin 5 to kill R..:.. 
gingivalis in the logarithmic stage of growth in a dose-dependent 
manner. In addition to this exciting finding, low pH favorably 
modulates the bactericidal effect of histatin 5 on P. gingivalis. 
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It is interesting to note that when the bacteria was incubated with 
histatin 5 at pH values of 7.0 or lower, the bactericidal activity 
of the protein increased. The bactericidal potency of histatin 5 
was increased as the pH value in which the protein was incubated 
with P. gingivalis decreased. When compared with other oral 
pathogens, the relative bactericidal and anti fungal potency of 
histatin 5 is much higher than for all other pathogens. This 
finding can be correlated with dentitions free of caries but 
affected with periodontal disease. The same inference can be made 
when comparing periodontal disease and candidiasis. 
The pH dependent changes observed between pHs 5.0 and 7.0 of 
histatin 5 suggest a potential contribution of histidine residues 
present in histatin 5. Raj et al. (1990) suggested that the helical 
conformation of histatin 5 might be important for its antifungal 
properties. The different pH values may change the conformation of 
histatin 5, making it more active in killing P. gingivalis. The 
growth inhibitory mechanisms of histatins on C. albicans have been 
reported to be concomitant with loss of potassium from the cells, 
suggesting that these peptides may also alter the membrane 
permeability and ionic gradient of the cells leading to their death 
(Pollock et al. 1984; Oppenheim et al 1989). The same mechanism 
might be true for the bactericidal activity of histatin 5 on g_,_ 
gingivalis. It has been reported that histatin 5 binds to this 
bacteria through cell membrane receptors (Murakami et al. 1990). 
The facts that P. gingivalis has cell membrane receptors for 
histatin 5 (Murakami et al. 1991) and the involvement of the cell 
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wall in the killing mechanism of histatin 5 on C. albicans suggest 
that the same bactericidal mechanism might be responsible for the 
loss of viability of P. gingivalis. More detailed evidence is 
needed to clarify the antimicrobial mechanism of histatin 5. 
Most of the peptide antibiotics of microbial origin are highly 
toxic, can cause allergic reactions, and most important, can create 
bacterial resistant to the drug. However, histatins-as natural 
salivary components-are non-toxic and, since they are present in 
body secretions,are non-allergenic. The constant presence of 
histatin 5 in the oral environment allows for direct interaction 
with P. gingivalis which may result in prevention of disease. 
Histatin 5 may represent the first line of host defense against --1:..z.. 
gingivalis-related periodontal disease. 
The potential pharmaceutical uses of histatin 5 in the 
prevention and/or therapy of P. gingivalis-related periodontal 
diseases seem very promising since it would make possible to 
improve the oral health of individuals prone to periodontal disease 
or at risk of future breakdown. The delivery of this peptide can be 
specifically targeted to infected sites via topical application by 
means of slow-release sustained delivery with histatin 5-
impregnated fibers placed subgingivally making the protein 
available at concentrations needed to inhibit and kill ~ 
gingivalis. Future research regarding antimicrobial mechanisms and 
in vivo research is needed to clarify and maximize the potential 
therapeutic uses of histatin 5. Also, the effect of histatin 5 on 
other suspected periodontal pathogens should be investigated. 
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CONCLUSIONS 
The purpose of this investigation was to determine the 
bactericidal effect of human salivary histatin 5 on the suspected 
periodontal pathogen Porphyromonas gingivalis. 
Histatin 5, isolated from human parotid secretions, exhibits 
the ability to kill P. gingivalis. The bactericidal activity was 
further elucidated at different pH values. At pH values of 5.0, 
6. 0, and 7. 0, histatin 5 has bactericidal activity against .E...... 
gingivalis. The LD50 values of histatin 5 at pHs 6.0 and 7.0 are 
0.19 mM and 0.51 mM, respectively. 
The relative bactericidal potency of histatin 5 for .E...,_ 
gingivalis is dependent on the pH of the protein environment. The 
bactericidal potency of histatin was inversely proportional to the 
pH value, it was higher at pH 5.0 and decreased as the pH value 
increased. 
This unique biological activity of salivary histatin 5 
suggests that it may play an important role in the non-immune host 
defense system of the oral cavity. Histatin 5 may play a preventive 
role in the host defense system against P. gingivalis-related 
periodontal diseases. Also, histatin 5 has a possible potential 
therapeutic role in the treatment of periodontal diseases. The 
bactericidal mechanism of human salivary histatin 5 is not known at 
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this stage. 
Future studies regarding th€ antimicrobial mechanism of 
histatin 5, the in vivo effect of histatin 5 on P. gingivalis, and 
the effect on other periodontal pathogens could lead to more 
understanding and clinical applications. 
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